DiscoveryProbe™ Microbiology & Virology-related Compounds Panel

Compound Panel Contents

Catalog No.	Product Name	Summary	Targets	CAS Number	Smiles
A8401	Clotrimazole	Antifungal compound	Microbiology &Virology|Antibiotic	23593-75-1	C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4
A5790	Cidofovir	Anti-CMV drug;inhibitor of viral DNA synthesis	Microbiology &Virology|CMV	113852-37-2	C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O
B1533	BMS-378806	Gp120/CD4 inhibitor	Microbiology &Virology|gp120/CD4	357263-13-9	CC1CN(CCN1C(=O)C(=O)C2=CNC3=NC=CC(=C23)OC)C(=O)C4=CC=CC=C4
A3444	GS-9620	TLR-7 agonist	Microbiology &Virology|HBV	1228585-88-3	CCCCOC1=NC2=C(C(=N1)N)NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4
A3546	Ledipasvir	HCV NS protein inhibitor	Microbiology &Virology|HCV	1256388-51-8	CC([C@@](/N=C(OC)\O)([H])C(N1CC2(C[C@@]1([H])C3=NC=C(N3)C4=CC5=C(C6=C(C5(F)F)C=C(C7=CC(N8)=C(N=C8[C@]9([H])[C@@]%10([H])CC[C@](N9C([C@](/N=C(OC)\O)([H])C(C)C)=O)([H])C%10)C=C7)C=C6)C=C4)CC2)=O)C
B1119	Efavirenz	Reverse transcriptase inhibitor	Microbiology &Virology|HIV	154598-52-4	C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
Download the Microbiology & Virology-related Compounds Panel - XLSX       Download the Microbiology & Virology-related Compounds Panel - SDF

Advantages

• Available in stock with overnight delivery and free shipping over $500
• Cost-effective and competitive price to save your findings
• Potent, selective and cell-permeable in inhibiting or activating target molecules
• Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.)
• Detailed files describing potency, selectivity and applications etc.
• Supported by published data from top peer-reviewed journals
• Guaranteed high quality with NMR and HPLC validation

产品描述
A wide range of well-characterized bioactive molecules that covers various targets related to microbiology & virology, including CCR5, HSV and CMV etc. Facilitate your research towards the insights of infection, immune diseases and cancer etc. Applicable in cellular assays, animal models and drug screenings etc.
References
1. Rower JE, Jimmerson LC, Chen X, Zheng JH, Hodara A, Bushman LR, Anderson PL, Kiser JJ. Validation and Application of a Liquid Chromatography-Tandem Mass Spectrometry Method To Determine the Concentrations of Sofosbuvir Anabolites in Cells. Antimicrob Agents Chemother. 2015 Dec;59(12):7671-9. 
Abstract 
Sofosbuvir (SOF) is a highly efficacious and well-tolerated uridine nucleotide analog that inhibits the hepatitis C virus (HCV) NS5B polymerase enzyme. We describe the validation and utilization of a method to characterize SOF's disposition into various in vivo cell types. Median concentrations in PBMC were 220, 70.2, and 859 fmol/10(6) cells in the monophosphate, diphosphate, and triphosphate fractions, respectively. In contrast, RBC triphosphate concentrations were much lower than those of PBMC, as the median concentration was 2.91 fmol/10(6) cells. The validated method and the data it generates provide novel insight into the cellular disposition of SOF and its phosphorylated anabolites in vivo.
2. Evers DL, Wang X, Huang ES. Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 2004 Oct;6(12):1084-93. 
Abstract 
Human cytomegalovirus (HCMV) receptor-ligand interactions and viral entry excite cellular responses such as receptor tyrosine kinase and mitogen-activated protein kinase signaling, cytoskeletal rearrangement, and the induction of transcription factors, prostaglandins, and cytokines. Bi-phasic stimulation of these pathways, excepting interferon, facilitates productive viral infection and likely contributes to viral pathogenesis.